Literature DB >> 21926963

Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myeloma.

O Landgren, W Ma, R A Kyle, S V Rajkumar, N Korde, M Albitar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21926963      PMCID： PMC7015347          DOI： 10.1038/leu.2011.262

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma.

Authors:  R Govindarajan; S Jagannath; J T Flick; D H Vesole; J Sawyer; B Barlogie; G Tricot
Journal:  Br J Haematol       Date:  1996-11       Impact factor: 6.998

2.  Associations between multiple myeloma and other malignancies.

Authors:  Ola Landgren; Aaron Polliack; Tamar Tadmor
Journal:  Leuk Lymphoma       Date:  2011-01-24

3.  Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma.

Authors:  Jens Hasskarl; Gabriele Ihorst; David De Pasquale; Percy Schröttner; Alf Zerweck; Ralph Wäsch; Monika Engelhardt
Journal:  Leuk Lymphoma       Date:  2010-11-05

4.  Multiple myeloma and acute myelomonocytic leukemia.

Authors:  R A Kyle; R V Pierre; E D Bayrd
Journal:  N Engl J Med       Date:  1970-11-19       Impact factor: 91.245

5.  Acute leukaemia and other secondary neoplasms in patients treated with conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study.

Authors: 
Journal:  Eur J Haematol       Date:  2000-08       Impact factor: 2.997

6.  The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia.

Authors:  D E Bergsagel; A J Bailey; G R Langley; R N MacDonald; D F White; A B Miller
Journal:  N Engl J Med       Date:  1979-10-04       Impact factor: 91.245

7.  Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.

Authors:  Bart Barlogie; Guido Tricot; Jeff Haessler; Frits van Rhee; Michele Cottler-Fox; Elias Anaissie; James Waldron; Mauricio Pineda-Roman; Raymond Thertulien; Maurizio Zangari; Klaus Hollmig; Abid Mohiuddin; Yazan Alsayed; Antje Hoering; John Crowley; Jeffrey Sawyer
Journal:  Blood       Date:  2007-09-25       Impact factor: 22.113

8.  Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome.

Authors:  Wanlong Ma; Hagop Kantarjian; Ke Zhang; Xi Zhang; Xiuqiang Wang; Clifford Chen; Amber C Donahue; Zhong Zhang; Chen-Hsiung Yeh; Susan O'Brien; Guillermo Garcia-Manero; Neil Caporaso; Ola Landgren; Maher Albitar
Journal:  BMC Med Genet       Date:  2010-11-16       Impact factor: 2.103

9.  A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults.

Authors:  J Cuzick; S Erskine; D Edelman; D A Galton
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640
  9 in total
  12 in total

1.  AML transformation after autologous stem cell transplant for multiple myeloma.

Authors:  Sanjeev Kumar Gupta; Jagan Chandramohan; Lalit Kumar
Journal:  BMJ Case Rep       Date:  2015-05-29

Review 2.  Second malignancies in multiple myeloma; emerging patterns and future directions.

Authors:  Kylee Maclachlan; Benjamin Diamond; Francesco Maura; Jens Hillengass; Ingemar Turesson; C Ola Landgren; Dickran Kazandjian
Journal:  Best Pract Res Clin Haematol       Date:  2020-01-11       Impact factor: 3.020

3.  The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study.

Authors:  Gudbjörg Jonsdottir; Sigrún H Lund; Magnus Björkholm; Ingemar Turesson; Malin Hultcrantz; Anna Porwit; Yogesh S Jethava; Ola Landgren; Sigurdur Y Kristinsson
Journal:  Blood Adv       Date:  2017-11-22

4.  Myeloma and second primary cancers.

Authors:  Ola Landgren; Anish Thomas; Sham Mailankody
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

5.  Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasia.

Authors:  X Papanikolaou; E R Rosenbaum; L N Tyler; J Sawyer; C J Heuck; B Barlogie; M Cottler-Fox
Journal:  Leukemia       Date:  2013-07-15       Impact factor: 11.528

6.  Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide?

Authors:  Sergio Matarraz; Bruno Paiva; María Diez-Campelo; Lucia López-Corral; Estefanía Pérez; Maria-Victoria Mateos; Pilar Giraldo; Miguel T Hernández; Jesús F San Miguel; Alberto Orfao
Journal:  Haematologica       Date:  2012-04-17       Impact factor: 9.941

7.  Longitudinal bone marrow evaluations for myelodysplasia in patients with myeloma before and after treatment with lenalidomide.

Authors:  Sara A Monaghan; Lijun Dai; Markus Y Mapara; Daniel P Normolle; Susanne M Gollin; Suzanne Lentzsch
Journal:  Leuk Lymphoma       Date:  2013-01-28

8.  Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia.

Authors:  Naveen Pemmaraju; Dhaval Shah; Hagop Kantarjian; Robert Z Orlowski; Graciela M Nogueras González; Veera Baladandayuthapani; Nitin Jain; Verena Wagner; Guillermo Garcia-Manero; Jatin Shah; Farhad Ravandi; Sherry Pierce; Koichi Takahashi; Naval Daver; Aziz Nazha; Srdan Verstovsek; Elias Jabbour; Marcos De Lima; Richard Champlin; Jorge Cortes; Muzaffar H Qazilbash
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-07-15

9.  Secondary primary malignancies in multiple myeloma: an old NEMESIS revisited.

Authors:  Jay Yang; Howard R Terebelo; Jeffrey A Zonder
Journal:  Adv Hematol       Date:  2012-07-19

10.  Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study.

Authors:  Huey-En Tzeng; Cheng-Li Lin; Chun-Hao Tsai; Chih-Hsin Tang; Wen-Li Hwang; Ya-Wen Cheng; Fung-Chang Sung; Chi-Jung Chung
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.